METASTATIC BILIARY TRACT CARCINOMA
Clinical trials for METASTATIC BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Morning vs. afternoon: can timing boost cancer immunotherapy?
Disease control Recruiting nowThis study looks at whether getting standard immunotherapy in the morning (before 11 am) or afternoon (after 12 pm) changes how well it fights advanced or metastatic solid tumors. Researchers think the body's internal clock (circadian rhythm) might affect immune activity. About 1…
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug cocktail aims to boost bile duct cancer treatment
Disease control Recruiting nowThis early-phase trial tests a new drug called emavusertib added to standard chemotherapy and immunotherapy for people with untreated advanced bile duct cancer. The goal is to see if the combination is safe and to find the best dose. About 48 participants will be enrolled.
Matched conditions: METASTATIC BILIARY TRACT CARCINOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC